PATRICIA POINDEXTER: Open Payments
NPI 1801861349 · PLAINFIELD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,417 in 269 payments from 22 companies in 2025. Trend: 2023 $3,788 · 2024 $3,029 · 2025 $3,417
Food & beverage: $3,417
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 22 | $479 |
| Otsuka America Pharmaceutical, Inc. | 29 | $449 |
| Supernus Pharmaceuticals, Inc. | 35 | $372 |
| Corium, LLC | 24 | $331 |
| Tris Pharma Inc | 53 | $289 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $214 |
| Neurocrine BioSciences, Inc. | 11 | $177 |
| Neos Therapeutics, LP | 10 | $175 |
| Collegium Pharmaceutical, Inc. | 20 | $140 |
| Vanda Pharmaceuticals Inc. | 5 | $118 |
Products named: REXULTI, Auvelity, Qelbree, Azstarys, Dyanavel XR, CAPLYTA, INGREZZA, Adzenys XR-ODT.
Industry payments across IN — which companies pay providers there.
